- ►diabetesjournals.org S Araki, D Koya, T Makiishi, T Sugimoto, M … - Diabetes Care, 2003 - Am Diabetes Assoc RESULTS—During the study (the mean follow-up period: 4.4 ± 1.0 years), 31 of
429 subjects progressed: 21 from normoalbuminuria to microalbuminuria and 10
from microalbuminuria to overt proteinuria. The allele frequency of the ... Cited by 54 - Related articles - BL Direct - All 5 versions
M Eto, M Saito, M Okada, Y Kume, F Kawasaki … - American Journal of Kidney Diseases, 2002 - Elsevier From the Department of Medicine, Diabetes and Endocrine Division, Kawasaki
Medical School, Kurashiki; and the Department of Medicine, Takada Central
Hospital, Bungo-takada, Japan. ... Background: We previously showed that ... Cited by 61 - Related articles - BL Direct - All 10 versions
S Araki, DK Moczulski, L Hanna, LJ Scott, JH … - Diabetes, 2000 - Am Diabetes Assoc The goal of this study was to examine the association between known
polymorphisms in the apolipoprotein E gene (APOE) and diabetic nephropathy (DN)
in type 1 dia- betes. We used both a case-control comparison and a fam- ily- ... Cited by 67 - Related articles - BL Direct - All 4 versions
- ►oxfordjournals.org [PDF] R Boize, P Benhamou, P Corticelli, K Valenti, … - Nephrology Dialysis Transplantation, 1998 - ERA-EDTA Page 1. Nephrol Dial Transplant (1998) 13: 72–75 Nephrology Dialysis
Transplantation Original Article ApoE polymorphism and albuminuria ... Cited by 38 - Related articles - BL Direct - All 5 versions
- ►oxfordjournals.org S Hadjadj, Y Gallois, G Simard, B Bouhanick, … - Nephrology Dialysis Transplantation, 2000 - ERA-EDTA Methods. We searched for a contribution of the genetic polymorphisms of
lipoprotein lipase (LPL), cholesteryl ester transfer protein (CETP) and
apolipoprotein (Apo E) to the development of diabetic nephropathy by ... Cited by 20 - Related articles - BL Direct - All 4 versions
M Eto, K Horita, A Morikawa, H Nakata, M … - Clin Genet, 1995 - interscience.wiley.com The genetic polymorphism of apolipoprotein E (ε2, ε3 and ε4) is associated
with lipid abnormalities. It has been suggested that lipid abnormalities may
contribute to the development and progression of kidney diseases, including ... Cited by 51 - Related articles - BL Direct - All 3 versions
- ►oxfordjournals.org L Tarnow, CDA Stehouwer, JJ Emeis, O … - Nephrology Dialysis Transplantation, 2000 - ERA-EDTA Background. A point mutation in the plasminogen activator inhibitor-1 (PAI-1)
gene and a three-allelic variation in the apolipoprotein-E (ApoE) gene have been
suggested as risk factors for the development of diabetic micro- and ... Cited by 43 - Related articles - BL Direct - All 4 versions
- ►oxfordjournals.org SK Ha, HS Park, KW Kim, SJ Kim, DH Kim, JH … - Nephrology Dialysis Transplantation, 1999 - ERA-EDTA Objectives. Apolipoprotein E (apo E) is known to play an important role in
lipoprotein metabolism through its ability to bind to the receptors as a ligand.
Three different apo E alleles ( 2, 3 and 4) produce six apo E genotypes ( ... Cited by 16 - Related articles - BL Direct - All 4 versions
